EyePoint Pharmaceuticals
EYPT
#10613
Rank
A$40.25 M
Marketcap
A$0.35
Share price
-11.36%
Change (1 day)
-98.33%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -A$0.45 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are A$2.78 Million. In 2025 the company made an earning of -A$0.35 Billion a decrease over its 2024 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.45 Billion28.05%
2025 -A$0.35 Billion63.24%
2024 -A$0.22 Billion104.29%
2023 -A$0.11 Billion-29.88%
2022 -A$0.15 Billion87.2%
2021 -A$79.96 Million38.58%
2020 -A$57.7 Million-24.56%
2019 -A$76.48 Million
2017 -A$34.88 Million22.59%
2016 -A$28.46 Million-8.02%
2015 -A$30.94 Million-296.09%
2014 A$15.77 M-174.02%
2013 -A$21.31 Million37.42%
2012 -A$15.51 Million-56.29%
2011 -A$35.48 Million-1062.38%
2010 A$3.68 M-250.43%
2009 -A$2.46 Million-89.5%
2008 -A$23.35 Million
2005 -A$14.4 Million56.99%
2004 -A$9.18 Million73.7%
2003 -A$5.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.27 Million-99.29% Bahamas
NRC Health
NRC
A$22.34 M-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA